Sign Up
Login
Try for Free
Login
The DASS-21 (Depression Anxiety Stress Scales, 21-item short form) is a public-domain self-report measure with three seven-item subscales, published by Lovibond and Lovibond in 1995 and scored over the past week. Psychologists, GPs, and counselors use it at intake and review, especially in Australia. It measures symptom severity; it never diagnoses. This page covers how to document and interpret DASS-21 results, with a fictional sample note.
Patient self-report (adult form from age 14 with adequate language; DASS-Y for younger children); scored and interpreted by the clinician; no license or qualification level required
Psychologists and counselors, GPs and prescribed medical practitioners under Better Access, headspace and PHN-commissioned services, primary care and university counseling teams, payers and auditors
3 to 8 chart lines (three subscales, doubled, with labels and change) · patient completion about 5 minutes
Self-report symptom scales (21 items in three 7-item subscales scored 0 to 3, past-week window; each subscale doubled to a 0 to 42 metric)
Intake baselines, treatment reviews and course-of-treatment reports, Better Access outcome measurement, program evaluation and research
Public domain (Psychology Foundation of Australia): copy freely, do not modify, sell, or host on a public website or app; named with the K10 as an example in Better Access guidance, mandated nowhere
The Depression Anxiety Stress Scales (DASS) are a set of self-report scales published by S. H. Lovibond and P. F. Lovibond, whose 1995 manual (second edition, Psychology Foundation, Sydney) is the controlling citation. The original instrument has 42 items, 14 per scale; the DASS-21 keeps seven per scale, chosen so that each short-form subscale runs at about half the full-scale value, which is why every adult DASS-21 subscale is multiplied by two before it is read against the manual's norms and the conventional severity ranges. Each item is rated 0 to 3 for the past week, so the raw subscale range is 0 to 21 and the doubled range is 0 to 42. The scales are dimensional and public domain, distributed by the Psychology Foundation of Australia through the UNSW DASS website, and a separate youth form (DASS-Y, 2022) exists for children and adolescents and is scored on its own metric, not doubled.
The load-bearing facts for documentation are three. First, there are three scores, not one: Depression, Anxiety, and Stress are scored and interpreted separately, and the rights holder's FAQ describes the Stress scale as a factorially distinct syndrome of nervous tension, difficulty relaxing, and irritability, not a count of life stressors, which is exactly what a single-number distress measure such as the K10 cannot show. Second, the severity labels (normal, mild, moderate, severe, extremely severe) are conventional population-relative ranges set at percentile cut points, and the rights holder calls the choice of any single clinical threshold necessarily arbitrary; a label describes where a score sits in the population, never a diagnosis. Third, the DASS-21 has no suicide or self-harm item, by design, so risk is assessed and documented separately. The disorder-anchored PHQ-9 and GAD-7 are the usual comparators in US and Canadian practice; the DASS-21 earns its place when the three-way profile matters.
Australia is the DASS-21's home market. The Better Access initiative expects a mental health treatment plan to include an outcome measurement tool unless clinically inappropriate, with the choice at the GP's or prescribed medical practitioner's discretion, and Commonwealth guidance (March 2026) names the K10 and the DASS-21 as examples, so GPs, psychologists, and counselors chart it at intake, at review points, and in the course-of-treatment report back to the referrer described on the Better Access treatment plan page. The K10 remains the incumbent for national reporting (the primary mental health care minimum data set, headspace, several state services), so many services run the K10 for comparability and add the DASS-21 when the depression, anxiety, and stress profile changes what they do. In Canada and the United States it lives in university counseling, integrated primary care, workers' compensation and insurer programs, and research, alongside or instead of the PHQ-9 and GAD-7; no payer in either country requires it. Serial results follow the conventions of the outcome measure note, and any risk finding is documented in a suicide risk assessment, because the DASS-21 cannot carry it.
No law in Australia, Canada, or the United States prescribes a DASS-21 note format, and the rights holder publishes scoring and cautions, not a template. What survives review is a record that names the version, language, and timeframe; reports three doubled subscale scores with their conventional labels; keeps the labels descriptive; states change per subscale; and records the separate risk assessment. Each element below carries the pitfall that most often undermines it.
Version, language, and timeframe. Chart adult DASS-21, DASS-42, or DASS-Y; the language and, where possible, the specific translation (the DASS site posts translations but does not verify their quality); the standard past-week timeframe; and the administration conditions (self-completed, interviewer-assisted, paper, or a restricted electronic workflow), with any literacy, comprehension, or missing-item concern and the prorating rule if one was used. Pitfall: "DASS-21" with no language or version, DASS-Y results trended against adult scores, or a changed timeframe that silently breaks comparability with the norms.
Three subscales, doubled. Sum the seven items in each subscale (raw 0 to 21), multiply each subscale by two, and chart both metrics: Depression raw 8/21, doubled 16/42. A fully completed, simply doubled adult DASS-21 gives even numbers; an odd or decimal score means prorating or a different metric and needs a note. DASS-Y is never doubled. Pitfall: Raw sums read against the doubled severity ranges (two tables circulate online), or a doubled score charted without saying so, so the next reader cannot tell which metric they are looking at.
Severity labels kept descriptive. Attach the conventional label to each doubled subscale: Depression 0 to 9 normal, 10 to 13 mild, 14 to 20 moderate, 21 to 27 severe, 28 and above extremely severe; Anxiety 0 to 7, 8 to 9, 10 to 14, 15 to 19, 20 and above; Stress 0 to 14, 15 to 18, 19 to 25, 26 to 33, 34 and above. The labels sit at population percentile cut points (about the 78th, 87th, 95th, and 98th) and describe range, not disorder. Pitfall: "DASS confirms severe anxiety disorder," "mild" read as a mild disorder, or extremely severe stress charted as an emergency in itself.
No unexplained total. Report the three subscales separately. If a composite is used, say so, name the method (the FAQ's approach converts each scale to a norm-referenced z score and averages), and name the norm set; never apply the subscale severity ranges to a sum. Pitfall: "DASS score 48, severe," a number no reader can decode: one subscale, an undoubled 21-item sum, a sum of doubled subscales, or a standardized composite.
The Stress scale and discordant profiles. Read Stress as tension, irritability, over-reactivity, and difficulty relaxing over the week, and preserve discordance: an extremely severe Stress score beside a normal Depression score is information about where the symptoms sit, to be examined against triggers, sleep, pain, substances, and function. Pitfall: The three scores averaged into one impression, or Stress reported as a measure of life stressors or burnout.
Change per subscale, in context. State the prior date, prior scores, and the change for each subscale (Anxiety 18 to 8, change of 10) on the same version, language, timeframe, and metric. Use descriptive language unless the service has adopted and named a reliable-change method and norm set. Note recent acute events: the past-week window means a result two days after a job loss is valid for that week but may not be a stable baseline. Pitfall: "DASS improved from 66 to 52," "reliably improved" with no method, or a single-week spike read as treatment failure.
Risk assessed separately. State that the DASS-21 contains no suicide or self-harm item and record the direct risk assessment, its findings, and the plan in the appropriate section; a low Depression score documents nothing about ideation, and an extremely severe score documents no intent. Pitfall: "Depression 6, normal, no risk concerns" with no direct inquiry, or the DASS-21 entered as the service's suicide screen.
DASS-21 DOCUMENTATION BLOCK Date: [ ] Setting: [ ] Clinician: [ ] Time point: [intake / review / course-of-treatment report / discharge] Version: [adult DASS-21 / DASS-42 / DASS-Y] Language + translation: [ ] Mode: [self-completed / interviewer-assisted; paper / restricted electronic] Timeframe: [past week (standard) / other: state and note comparability] Completeness: [all items answered / missing items + prorating rule used] Depression: raw [ ]/21 -> x2 = [ ]/42 [normal / mild / moderate / severe / extremely severe] Anxiety: raw [ ]/21 -> x2 = [ ]/42 [label] Stress: raw [ ]/21 -> x2 = [ ]/42 [label] (DASS-Y: report on its own metric, not doubled) Prior administration: [date] D [ ] A [ ] S [ ] Change per subscale: [ ] Interpretation: [labels are conventional population-relative ranges, not diagnoses; no total reported; profile and context: acute events, sleep, pain, substances, function; congruence with interview] Risk: [DASS-21 has no suicide item; direct risk assessment done: findings, formulation, plan documented at ...] Plan: [treatment focus / next administration and purpose / report to referrer] Clinician signature / credentials: Date:
Free to use and share, no signup. The PDF includes a one-page cheat sheet with element-by-element pitfalls and a pre-sign checklist; the DOCX is the blank documentation block, ready to adapt. Neither reproduces the scale items or forms.
Scenario: an Australian private-practice review at the end of an initial Better Access course of treatment, with a repeat DASS-21 showing improvement in two subscales and persistent stress, risk assessed separately, and the report back to the referring GP. All details are fictional.
Patient: T.L., 34 · Setting: Private psychology practice, Better Access review (session 6) · Clinician: R. Whitfield, Clinical Psychologist · Note date: 08/12/2026
Measure: DASS-21, adult English version, self-completed on paper in the waiting room before session 6, standard past-week timeframe, all 21 items answered. Raw subscale sums: Depression 8/21, Anxiety 4/21, Stress 14/21. Doubled for comparison with DASS norms and the conventional ranges: Depression 16/42 (moderate), Anxiety 8/42 (mild), Stress 28/42 (severe). Baseline at intake, 07/01/2026, same version and conditions: Depression 24/42 (severe), Anxiety 18/42 (severe), Stress 30/42 (severe).
Interpretation: Change by subscale: Depression 24 to 16 (down 8), Anxiety 18 to 8 (down 10), Stress 30 to 28 (down 2). Depressive and anxiety symptoms decreased over the six sessions; tension, irritability, and difficulty relaxing remain in the severe range, consistent with the ongoing workplace conflict T.L. described during both measurement weeks. Labels are conventional population-relative ranges, not diagnoses; no total is reported; the practice has not adopted a reliable-change rule for this measure, so change is described rather than labelled significant. Result congruent with today's interview: improved mood and fewer panic-like episodes, continued poor sleep before shifts and irritability at home.
Risk: The DASS-21 contains no suicide or self-harm item. Risk assessed directly today: denies thoughts of self-harm or suicide since the last review, no plan or intent, no self-harm behavior, protective factors unchanged (partner, work role, treatment engagement); formulation and safety planning recorded in the risk section of the record.
Plan and report: Initial course of treatment complete. Recommend a further course under the existing plan focused on arousal reduction, sleep, and workplace boundaries; re-administer the DASS-21 at the final session of the next course. Written report to the referring GP today as required at the end of the course: intake and current scores for all three doubled subscales with their ranges, change per subscale, current functioning, the separate risk conclusion, and the recommendation. Session claimed under item 80010 per the referral.
Administrative: Scores entered in the practice's outcome-measure record with version, language, timeframe, and both metrics; the K10 is not used by this practice for this client, and the referral did not specify an instrument.
This sample is fictional and for educational purposes. It does not describe a real patient or record; the scores, dates, and details are invented to show documentation structure and are not clinical guidance.
Writing these after every session? BastionGPT drafts complete notes from bullets, dictation, or a transcript.
Generate a note from bulletsAustralia: outcome measurement is expected; the instrument is a choice. No Australian law names the DASS-21. Under Better Access (PAYER POLICY, via Medicare eligibility and claiming rules), Commonwealth guidance updated in March 2026 says a mental health treatment plan must include an assessment, an outcome measurement tool unless clinically inappropriate, and a provisional or formal diagnosis, with the tool at the GP's or prescribed medical practitioner's clinical discretion and the K10 and DASS-21 named as examples; there is no mandated DASS-21 template, format, or interval. Current plan-preparation items (Services Australia, June 2026) are 2700, 2701, 2715, and 2717 for GPs and 272, 276, 281, and 282 for prescribed medical practitioners, with video equivalents 92112, 92113, 92116, 92117, 92118, 92119, 92122, and 92123. The dedicated review and ongoing-management items (2712, 2713, and their equivalents) were removed on 1 November 2025 and reviews now use applicable general attendance items, so any page still directing a GP to 2712 is obsolete; a plan does not expire, a new plan is generally not prepared within 12 months, and reviews ordinarily occur no more than once every three months and not within four weeks of plan preparation (PAYER POLICY, and rules about the plan, not a DASS administration schedule). The K10 is the system-level incumbent (CONVENTION): it is the standard consumer measure in the primary mental health care minimum data set, headspace's principal outcome measure, and mandatory in several state and territory specialized services, which is why many services keep the K10 for comparability and add the DASS-21 for the profile. The November 2025 Better Access reforms carry a post-implementation review with no fixed date.
United States and Canada: no requirement, and specific billing limits. No US federal law or payer names the DASS-21; PHQ-9 and GAD-7 hold the primary-care and quality-measure slots. Brief standardized emotional or behavioral assessment is reported under 96127 (PAYER POLICY): the code is structured per instrument, one completed, scored, and documented instrument is one unit, three DASS-21 subscales do not automatically justify three units absent explicit payer direction, commercial payers commonly cap the code at four units per date of service and traditional Medicare at three, and Medicare's annual depression screening runs through G0444 rather than 96127; the CY 2027 physician fee schedule was still a proposed rule in August 2026, so recheck payer policy after it finalizes. In Canada, no federal or provincial law or payer names the DASS-21: Ontario Health's anxiety quality standard calls for validated tools and regular measurement without prescribing one, WSIB's community mental health program requires its progress form after every sixth session or eighth week without naming an instrument, and family health teams publish DASS-21 scoring guides for local use (CONVENTION and program PAYER POLICY; verify each contract). On the evidence: the 1995 severity framework rests on a development sample of 717 first-year psychology students, the UK adult norms are from 2005 (1,794 adults; alphas .88 Depression, .82 Anxiety, .90 Stress, .93 for the 21-item total), and Australian adult percentile norms from 2011, so a percentile or z score should name its norm set. The scales intercorrelate around .5 to .7, and the modern factor-analytic literature (Henry and Crawford 2005; Osman and colleagues 2012; Zanon and colleagues across eight countries in 2021 and nine in 2025) finds a strong general-distress factor beneath the three specific factors, which is the reason to read small subscale differences modestly, not a reason to stop reporting three scores. A 2019 COSMIN review of 48 studies rated responsiveness evidence low for Depression and Stress and very low for Anxiety, so no universal minimal-change threshold is established; a Chichewa-language study in Malawi reported an Anxiety alpha of 0.29, a reminder that translation availability is not local validation.
Rights are precise and easy to overstate. The DASS is described by its rights holder as public domain: the forms may be downloaded and copied without restriction, but they may not be modified or sold for profit, computerized administration is permitted with results going to the clinician or researcher, automated interpretation returned to respondents is discouraged as misleading and potentially dangerous, and a website or app open to members of the public (a clinical practice website is the FAQ's own example) is not permitted; the allowed digital model is a restricted, defined group such as enrolled patients with results routed to the clinician. A clinician may charge for an assessment that includes the DASS; the scales themselves may not be sold. Translations must remain public domain and cannot be copyrighted or sold, and no separate translator permission is needed for versions posted on the DASS site, which does not verify their quality. The correct citation is the 1995 manual, and professional publications are asked to cite the permanent DASS website. The DASS-Y (ages 8 to 17 on the site) is a standalone youth form on its own metric. The Depression Anxiety Stress Scales are distributed by the Psychology Foundation of Australia through the UNSW DASS website. BastionGPT is not affiliated with, or endorsed by, the Psychology Foundation of Australia, UNSW, or the instrument's authors. This page reproduces no items, response options, or forms and describes the scoring conventions in original prose.
The numbers behind these errors are specific. The conventional severity labels sit at population percentile cut points of about the 78th, 87th, 95th, and 98th, derived from a 1995 development sample of 717 first-year psychology students; the three scales intercorrelate around .5 to .7 and share a strong general-distress factor in eight-country and nine-country analyses; a 2019 COSMIN review of 48 studies rated responsiveness evidence low or very low, so no universal minimal-change threshold exists; and no published audit quantifies how often the multiply-by-two step is skipped, only that two incompatible cutoff tables circulate online. The BastionGPT Clinical Advisory Board sees the same errors most often in DASS-21 documentation reviews:
BastionGPT is specifically trained, tuned, and clinically tested on behavioral health progress notes and screening documentation.
See how clinicians use it day to day on the AI therapy notes page.
Many BastionGPT users report saving more than 90 minutes per day on documentation.
HIPAA-compliant with a signed BAA on every plan. Your data is never used to train models. BastionGPT drafts, you review and sign.
Yes, for the adult DASS-21. Each of the three subscales (Depression, Anxiety, Stress) sums seven items rated 0 to 3 for the past week, giving a raw 0 to 21; multiply each subscale by two to reach the 0 to 42 metric on which the manual's norms and the conventional severity ranges are defined. On that doubled metric, Depression runs 0 to 9 normal, 10 to 13 mild, 14 to 20 moderate, 21 to 27 severe, and 28 and above extremely severe; Anxiety 0 to 7, 8 to 9, 10 to 14, 15 to 19, and 20 and above; Stress 0 to 14, 15 to 18, 19 to 25, 26 to 33, and 34 and above. Chart both metrics (raw 8/21, doubled 16/42, moderate) so the next reader knows which they are looking at, and remember that a fully completed, simply doubled adult DASS-21 gives even numbers. Do not multiply a grand total, and never multiply the DASS-Y, which is scored on its own metric.
Not in ordinary clinical scoring. The three subscales are reported and interpreted separately, and there is no official severity table for a raw grand total, so "DASS score 48, severe" cannot be decoded (one subscale? an undoubled 21-item sum? a sum of doubled subscales?). The rights holder's FAQ does permit a composite measure of negative emotional symptoms, mainly for research, and recommends converting each scale to a norm-referenced z score and averaging the standardized values; if you use one, say so, name the method and the norm set, and never apply the subscale ranges to it. Collapsing the three scores also throws away the discordance (severe Stress with normal Depression, say) that is the instrument's advantage over a single-number distress measure.
No. The labels mark positions in a population distribution, at percentile cut points of about the 78th (normal to mild), 87th (mild to moderate), 95th (moderate to severe), and 98th (severe to extremely severe), and the rights holder's own FAQ says the selection of any single clinical threshold is necessarily arbitrary and that "mild" means above the population mean while still well below the level typical of people seeking treatment, not a mild disorder. Extremely severe Stress is not a stress disorder, a burnout diagnosis, or an emergency by itself; normal Depression does not exclude a depressive disorder or any risk. Chart the range and interpret it with the interview, duration, impairment, context, and differential, in language like "score falls in the conventional extremely severe range; interpret with the clinical assessment," never "DASS confirms severe anxiety disorder."
No authority requires it by name. In Australia, Better Access guidance (March 2026) says a mental health treatment plan must include an outcome measurement tool unless clinically inappropriate, with the choice at the GP's or prescribed medical practitioner's discretion, and names the K10 and DASS-21 as examples; the K10 remains the incumbent for national reporting, so services often keep it for comparability and add the DASS-21 for the profile. Current plan-preparation items are 2700, 2701, 2715, 2717, 272, 276, 281, and 282 with video equivalents; the dedicated review items (2712 and its equivalents) were removed on 1 November 2025 and reviews now use general attendance items, and neither the plan rules nor the reviews set a DASS administration schedule. In the United States there is no mandate; brief standardized assessment is reported per instrument under 96127, with commercial caps commonly at four units a day and Medicare at three, and three subscales do not automatically make three units. In Canada, no federal or provincial payer names it; verify each program's own form and cadence (WSIB, for example, requires its progress form after every sixth session or eighth week without naming a tool). See the Better Access treatment plan page for the plan and referral rules.
EHR yes, public website or app no. The rights holder describes the DASS as public domain: the forms may be downloaded, printed, and copied without restriction, and computerized administration is permitted, provided the scales are not modified or sold and the results go to the clinician or researcher rather than being interpreted automatically for the respondent, which the FAQ calls misleading and potentially dangerous. A website or app intended for or open to members of the public (the FAQ's own example is a clinical practice website) is not permitted, whether or not it is free; the allowed digital model is a restricted, defined group such as enrolled patients or research participants with results routed to the clinician. A clinician may charge for an assessment that includes the DASS; the scales themselves may not be sold, and translations must remain public domain and cannot be copyrighted or sold. Terms are as stated on the UNSW DASS site in August 2026; cite the 1995 manual.
It means the client endorsed a high level of tension, irritability, over-reactivity, and difficulty relaxing during the measurement week relative to the conventional population ranges, and it is a legitimate, informative profile rather than an error. It does not by itself establish a stress disorder, generalized anxiety disorder, burnout, malingering, or a need for emergency care. Assess the precipitating events, duration, sleep, pain, substances, medical contributors, agitation, trauma-related symptoms, and functional impairment, and let the interview carry the diagnostic weight; the modern factor literature also finds a strong general-distress component under all three scales, so read small subscale gaps modestly. Preserve the three scores in the chart; a discordant profile is exactly the case for reporting them separately.
Treat the DASS-21 as unable to rule suicide or self-harm risk in or out. The scales contain no suicide item because candidate items did not load on any of the three scales during development, and the rights holder's guidance says experienced clinicians must assess risk separately in seriously disturbed patients. So: a low Depression score documents nothing about ideation, an extremely severe score documents no intent, and the DASS-21 cannot satisfy a suicide-screening workflow. Run the service's direct risk assessment whenever it is clinically indicated, and record in the DASS entry that risk was assessed separately, with the findings, formulation, and plan in a suicide risk assessment or the risk section of the record. If your workflow needs a self-harm item in the questionnaire itself, the PHQ-9 has one, with its own follow-up rules.
Choose the DASS-21 when the three-way profile matters, especially to isolate the tension and over-arousal domain that a single-number measure cannot show, and when past-week monitoring fits the cadence. Choose the K10 when one global distress score over four weeks, lower burden, and compatibility with Australian national and service reporting are the priorities; running both needs a defined purpose. Choose the PHQ-9 and GAD-7 when disorder-anchored measures with validated cutoffs, a self-harm item, and US and Canadian payer familiarity matter. Choose the DASS-42 when more reliable subscales and more symptom detail justify twice the length; the rights holder describes the full form as often preferable for clinical work. Use the DASS-Y for children and adolescents (ages 8 to 17 on the DASS site; the adult form is acceptable from 14 with adequate language), scored on its own metric, never doubled, and never trended against adult scores.
Yes. Give it the facts (version and language, timeframe, mode, raw subscale sums or the completed form, prior scores and dates, context, and the risk assessment findings) and it drafts the full entry: doubled scores with their ranges, change per subscale, a descriptive interpretation, the separate risk line, and the report back to the referrer, ready for your review. It can also check a finished note for raw sums read against the doubled ranges, an unexplained total, a label charted as a diagnosis, discordance flattened, and a risk conclusion drawn from the Depression score. BastionGPT is HIPAA-compliant with a signed BAA on every plan, and your data is never used to train models.
The instrument facts and compliance claims on this page trace to these sources, last verified August 2026:
Educational content, not legal or billing advice. Sample notes are fictional. Follow your organization's policies and your board, payer, and jurisdiction requirements.